8329 — Shenzhen Neptunus Interlong Bio-technique Share News
0.000.00%
Last trade - 00:00- HK$152.70m
- HK$81.58m
- CNY972.01m
Brief: Shenzhen Neptunus Interlong Bio-Technique Says Unit Entered Technology Transfer Agreement With Neptunus Research
Brief: Shenzhen Neptunus Interlong Bio-Technique Co Proposes Zhou Hang Be Appointed Executive Director
Brief: Shenzhen Neptunus Interlong Bio-Technique Says Ribavirin Product Added To Treatment Plans Of Coronavirus
Brief: Shenzhen Neptunus Interlong Bio-Technique Says Unit Entered Agreement With Neptunus Bio-Engineering
Brief: Shenzhen Neptunus Interlong Bio-Technique Says Unit Entered Development Agreement With Neptunus Research
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts Q1 Net Profit Of RMB12.1 Mln
Brief: Shenzhen Neptunus Interlong Bio-Technique Updates On Unit's SODIUM BICARBONATE TABLETS
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Profit And Total Comprehensive Income of RMB51.1 Mln
Brief: Shenzhen Neptunus Interlong Bio-Technique Says Unit Acquired Pharmaceutical GMP Certificate
Brief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Sales Management Service Agreement
Brief: Shenzhen Neptunus Interlong Bio-Technique Co Says Unit Entered Into Distribution Agreement
Brief: Shenzhen Neptunus Interlong Bio-Technique Says Unit Receivies Administrative Penalty
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects A Decrease In Profit Attributable For HY
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts Q1 Profit Attributable RMB12.7 Mln
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Profit & Total Comprehensive Income Attributable RMB50.3 Mln
Brief: Shenzhen Neptunus Interlong Bio-Technique Co posts qtrly net profit rmb 12.563 mln
Brief: Shenzhen Neptunus Interlong Bio-Technique updates on Lianjiang project
Brief: Shenzhen Neptunus Interlong Bio-Technique's unit enters sales management service deal
Brief: Shenzhen Neptunus Interlong Bio-Technique says Fujian FDA withdrew unit's certificate